Trials / Not Yet Recruiting
Not Yet RecruitingNCT06510413
An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers
An Bioequivalence Study of Loxoprofen Sodium Patches in Chinese Healthy Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Frontier Biotechnologies Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study was a single-center, randomized, open-label, two-agent, two-cycle, double-cross bioequivalence trial.
Detailed description
The objectives of this study are to evaluate the difference of absorption degree and absorption rate of two kinds of patches( FB3002 vs. Loxonin®) in Chinese healthy population, and to assess the bioavailability of these two patches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Loxoprofen Sodium Patches(reference product) | Single dose of one patch in each period; Apply for 24 hours each time |
| DRUG | Loxoprofen Sodium Patches(test product ) | Single dose of one patch in each period; Apply for 24 hours each time |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
- First posted
- 2024-07-19
- Last updated
- 2024-07-19
Source: ClinicalTrials.gov record NCT06510413. Inclusion in this directory is not an endorsement.